Global Protein Sequencing Market to Reach $1.3 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Protein Sequencing estimated at US$1. 1 Billion in the year 2020, is projected to reach a revised size of US$1. 3 Billion by 2027, growing at aCAGR of 2.

New York, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Protein Sequencing Industry" - https://www.reportlinker.com/p06032698/?utm_source=GNW
1% over the period 2020-2027. Mass Spectrometry, one of the segments analyzed in the report, is projected to record 1.9% CAGR and reach US$808.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Edman Degradation segment is readjusted to a revised 2.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $319.5 Million, While China is Forecast to Grow at 2% CAGR

The Protein Sequencing market in the U.S. is estimated at US$319.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$225.9 Million by the year 2027 trailing a CAGR of 2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.9% and 1.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Select Competitors (Total 34 Featured) -
Agilent Technologies
Bioinformatics Solution
Charles River Laboratories
Proteome Factory
Rapid Novor
Selvita
SGS (SA)
Shimadzu Corp.
Thermo Fischer Inc.
Water Corporation


Read the full report: https://www.reportlinker.com/p06032698/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Protein Sequencing - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Protein Sequencing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Protein Sequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Protein Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for Mass
Spectrometry by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Mass Spectrometry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Mass Spectrometry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Edman
Degradation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Edman Degradation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Edman Degradation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Biotherapeutics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Biotherapeutics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Biotherapeutics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Genetic Engineering by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Genetic Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Genetic Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Academic Institutes & Research Centers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Academic Institutes &
Research Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Academic Institutes &
Research Centers by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Pharma & Biotech Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 28: World Protein Sequencing Market Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 30: USA Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 31: USA 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 32: USA Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 33: USA Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 34: USA 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 35: USA Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 36: USA Historic Review for Protein Sequencing by End-Use -
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 37: USA 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 39: Canada Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 40: Canada 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 41: Canada Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 42: Canada Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 43: Canada 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 44: Canada Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 45: Canada Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 46: Canada 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

JAPAN
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 48: Japan Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 49: Japan 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 50: Japan Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 51: Japan Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 52: Japan 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 53: Japan Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 54: Japan Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 55: Japan 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

CHINA
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 56: China Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 57: China Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 58: China 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 59: China Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 60: China Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 61: China 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 62: China Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 63: China Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 64: China 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

EUROPE
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Protein Sequencing by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 66: Europe Historic Review for Protein Sequencing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 67: Europe 15-Year Perspective for Protein Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2021 & 2027

Table 68: Europe Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 69: Europe Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 70: Europe 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 71: Europe Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 72: Europe Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 73: Europe 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 74: Europe Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 75: Europe Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 76: Europe 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

FRANCE
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 77: France Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 78: France Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 79: France 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 80: France Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 81: France Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 82: France 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 83: France Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 84: France Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 85: France 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

GERMANY
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 87: Germany Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 88: Germany 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 89: Germany Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 90: Germany Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 91: Germany 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 92: Germany Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 93: Germany Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 94: Germany 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 96: Italy Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 97: Italy 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 98: Italy Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 99: Italy Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 100: Italy 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 101: Italy Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 102: Italy Historic Review for Protein Sequencing by
End-Use - Academic Institutes & Research Centers, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 103: Italy 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

UNITED KINGDOM
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Protein Sequencing by Technology - Mass Spectrometry and Edman
Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 105: UK Historic Review for Protein Sequencing by
Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 106: UK 15-Year Perspective for Protein Sequencing by
Technology - Percentage Breakdown of Value Sales for Mass
Spectrometry and Edman Degradation for the Years 2012, 2021 &
2027

Table 107: UK Recent Past, Current & Future Analysis for
Protein Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 108: UK Historic Review for Protein Sequencing by
Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 109: UK 15-Year Perspective for Protein Sequencing by
Application - Percentage Breakdown of Value Sales for
Biotherapeutics, Genetic Engineering and Other Applications for
the Years 2012, 2021 & 2027

Table 110: UK Recent Past, Current & Future Analysis for
Protein Sequencing by End-Use - Academic Institutes & Research
Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 111: UK Historic Review for Protein Sequencing by End-Use -
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 112: UK 15-Year Perspective for Protein Sequencing by
End-Use - Percentage Breakdown of Value Sales for Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses for the Years 2012, 2021 & 2027

REST OF EUROPE
Table 113: Rest of Europe Recent Past, Current & Future
Analysis for Protein Sequencing by Technology - Mass
Spectrometry and Edman Degradation - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 114: Rest of Europe Historic Review for Protein
Sequencing by Technology - Mass Spectrometry and Edman
Degradation Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 115: Rest of Europe 15-Year Perspective for Protein
Sequencing by Technology - Percentage Breakdown of Value Sales
for Mass Spectrometry and Edman Degradation for the Years 2012,
2021 & 2027

Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Protein Sequencing by Application -
Biotherapeutics, Genetic Engineering and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 117: Rest of Europe Historic Review for Protein
Sequencing by Application - Biotherapeutics, Genetic
Engineering and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 118: Rest of Europe 15-Year Perspective for Protein
Sequencing by Application - Percentage Breakdown of Value Sales
for Biotherapeutics, Genetic Engineering and Other Applications
for the Years 2012, 2021 & 2027

Table 119: Rest of Europe Recent Past, Current & Future
Analysis for Protein Sequencing by End-Use - Academic
Institutes & Research Centers, Pharma & Biotech Companies and
Other End-Uses - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 120: Rest of Europe Historic Review for Protein
Sequencing by End-Use - Academic Institutes & Research Centers,
Pharma & Biotech Companies and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 121: Rest of Europe 15-Year Perspective for Protein
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Academic Institutes & Research Centers, Pharma & Biotech
Companies and Other End-Uses for the Years 2012, 2021 & 2027

ASIA-PACIFIC
Protein Sequencing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Protein Sequencing by Technology - Mass Spectrometry and
Edman Degradation - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 123: Asia-Pacific Historic Review for Protein Sequencing
by Technology - Mass Spectrometry and Edman Degradation Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 124: Asia-Pacific 15-Year Perspective for Protein
Sequencing by Technology - Percentage Breakdown of Value Sales
for Mass Spectrometry and Edman Degradation for the Years 2012,
2021 & 2027

Table 125: Asia-Pacific Recent Past, Current & Future Analysis
for Protein Sequencing by Application - Biotherapeutics,
Genetic Engineering and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 126: Asia-Pacific Historic Review for Protein Sequencing
by Application - Biotherapeutics, Genetic Engineering and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 127: Asia-Pacific 15-Year Perspective for Protein
Sequencing by Application - Percentage Breakdown of Value Sales
for Biotherapeutics, Genetic Engineering and Other Applications
for the Years 2012, 2021 & 2027

Table 128: Asia-Pacific Recent Past, Current & Future Analysis
for Protein Sequencing by End-Use - Academic Institutes &
Research Centers, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032698/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001